Medicared For All Logo

Noa Biran in Hackensack, New Jersey

Home New Jersey Hackensack

Noa Biran has Hematology/oncology as her primary medical specialty. Their primary office is: 92 2nd St in Hackensack, New Jersey.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended George Washington University School Of Medicine and graduated in 2008 (around 16 years of experience). They are listed as doing telehealth appointments.

Noa Biran Office Phone and Directions

Noa Biran
Regional Cancer Care Associates Llc
92 2nd St
Hackensack, New Jersey 07601
201-996-5900

Patient Ratings
Please rate your experience with Noa Biran below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 201-996-5900


Enter a starting address:


Healthcare Info for Noa Biran

Medical School: George Washington University School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for Noa Biran is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 5496971921
NPI #: 1023277910
NPI Created On: 06/05/2008
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA09466300
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

  1. Diagnostic bone marrow aspiration
  2. Bone marrow biopsy
  3. Bone marrow biopsy and aspiration
  4. Complete blood cell count (red cells, white blood cell, platelets), automated test
  5. Bone marrow, smear interpretation
  6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  7. New patient office or other outpatient visit, typically 60 minutes
  8. Established patient office or other outpatient visit, typically 15 minutes
  9. Established patient office or other outpatient, visit typically 25 minutes
  10. Established patient office or other outpatient, visit typically 40 minutes
  11. Initial hospital inpatient care, typically 70 minutes per day
  12. Subsequent hospital inpatient care, typically 35 minutes per day
  13. Hospital discharge day management, 30 minutes or less
  14. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  15. Injection, epoetin alfa, (for non-esrd use), 1000 units
  16. Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,768

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788947815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788947807

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,000

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788947805

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $550

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788947809

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788947811

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788947813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801674849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Hematology/oncology Professionals in Hackensack

1.
Mark Pascal

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

2.
Richard Scher DO

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

3.
Harry Harper

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

4.
Sukhdeep Kaur

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

5.
Robert Tassan MD

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

6.
Kelley Mowatt Pesce

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group


Medicared For All
Vote!
Share